endometriosis.
Conditions
Interventions
Intervention group: Patients with endometriosis with pain, according to the doctor's diagnosis for drug treatment of pain Dinogen 2 mg per day orally (tablets) (Iran Hormone Company) once a day for 6
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Women aged 18-44 years with pain and suspected endometriosis Do not take hormonal drugs containing estrogen or progesterone for three months No pregnancy Absence of genital or breast cancers No abnormal vaginal bleeding No breastfeeding for 3 months Do not use housing during the last week No surgery in the last 3 months No liver problems No strong history of venous thrombosis or embolism Body mass index 5 / 18-26
Exclusion criteria
Exclusion criteria: Has a history of any genital cancer in the pelvic area Hormone therapy for the past 3 months Suffering from a variety of systemic diseases History of endometrial destruction by thermal balloon or resectoscope
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intensity of pain. Timepoint: 3 months and 6 months later. Method of measurement: Vas score questionnaire.;The amount of CGRP neuropeptide. Timepoint: 6 months later. Method of measurement: ELISA device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMarziyeh Ajdary-Iran University of Medical Sciences
Iran University of Medical Sciences
Outcome results
None listed